Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:50 pm Sale | 2024-12-31 | 13G | API GROUP CORP COM APG | VIKING GLOBAL INVESTORS LP | 32,306,277 7.800% | -8,242,497 (-20.33%) | Filing History |
| 2025-01-31 7:18 pm Sale | 2025-01-31 | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 22,055,375 11.700% | -3,065,616 (-12.20%) | Filing History |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | VIKING GLOBAL INVESTORS LP | 0 0.000% | -328,962 (Position Closed) | Filing History |
| 2024-11-14 4:31 pm Unchanged | 2024-09-30 | 13G | GINKGO BIOWORKS HLDGS INC DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 8.300% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 1,481,146 1.600% | -4,678,000 (-75.95%) | Filing History |
| 2024-11-14 4:31 pm Unchanged | 2024-09-30 | 13G | PEPGEN INC PEPG | VIKING GLOBAL INVESTORS LP | 1,482,434 4.500% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 0 0.000% | -4,247,914 (Position Closed) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | ROIVANT SCIENCES LTD SHS ROIV | VIKING GLOBAL INVESTORS LP | 54,099,066 7.300% | -15,269,895 (-22.01%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | VIKING THERAPEUTICS INC VKTX | VIKING GLOBAL INVESTORS LP | 721,926 0.600% | -4,423,186 (-85.97%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | VERASTEM INC VSTM | VIKING GLOBAL INVESTORS LP | 0 0.000% | -2,531,829 (Position Closed) | Filing History |
| 2024-11-06 5:04 pm Unchanged | 2024-08-16 | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 13.400% | 0 (Unchanged) | Filing History |
| 2024-11-06 5:03 pm Unchanged | 2024-02-01 | 13D | CAZOO GROUP LTD OCT 2023 CZOOF | VIKING GLOBAL INVESTORS LP | 2,142,728 43.800% | 0 (Unchanged) | Filing History |
| 2024-09-30 4:29 pm Purchase | 2024-09-20 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VIKING GLOBAL INVESTORS LP | 9,753,293 5.100% | 9,753,293 (New Position) | Filing History |
| 2024-08-20 8:42 pm Unchanged | 2024-08-16 | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 13.400% | 0 (Unchanged) | Filing History |
| 2024-07-15 4:17 pm Purchase | 2024-07-03 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | VIKING GLOBAL INVESTORS LP | 1,752,656 5.200% | 1,752,656 (New Position) | Filing History |
| 2024-06-18 5:05 pm Sale | 2024-06-17 | 13G | API GROUP CORP COM APG | VIKING GLOBAL INVESTORS LP | 40,548,774 9.900% | -7,485,598 (-15.58%) | Filing History |
| 2024-06-07 4:23 pm Purchase | 2024-05-29 | 13G | INHIBRX BIOSCIENCES INC INBX | VIKING GLOBAL INVESTORS LP | 1,787,705 12.300% | 1,787,705 (New Position) | Filing History |
| 2024-06-03 5:56 pm Sale | 2024-05-30 | 13G | INHIBRX INC INBX | VIKING GLOBAL INVESTORS LP | 0 0.000% | -7,150,826 (Position Closed) | Filing History |
| 2024-03-20 6:05 pm Purchase | 2024-03-18 | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.300% | 29,544,805 (+101.51%) | Filing History |
| 2024-03-01 4:18 pm Sale | 2024-02-28 | 13G | API GROUP CORP COM APG | VIKING GLOBAL INVESTORS LP | 48,034,372 12.300% | -15,741,364 (-24.68%) | Filing History |